Significant Ownership of KH Feelux Co., Ltd

Signature - Title
/s/ Bosung Bae - Bosung Bae, CEO
Location
Seoul
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by KH Feelux Co., Ltd.

Notify me when KH Feelux Co., Ltd files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of KH Feelux Co., Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LIMN Liminatus Pharma, Inc. Common Stock, $0.0001 par value per share 15% $26,400,000 4,000,000 KH Feelux Co., Ltd 30 Apr 2025

Schedules 13D/G Reported by KH Feelux Co., Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.